Advancing HFpEF Treatment with Novel MRAs - Episode 4
Quality of Life and Hospitalization Burden in HFpEF
Panelists emphasize strategies to enhance patient quality of life and reduce hospital readmissions through optimized therapeutic management.
Panelists emphasized that reducing hospitalizations and improving quality of life are key goals in heart failure with preserved ejection fraction management. They noted that symptom burden—fatigue, breathlessness, and limited exercise tolerance—can severely affect daily living even when ejection fraction remains preserved.
Therapies such as mineralocorticoid receptor antagonists, sodium-glucose transporter 2 inhibitors, and diuretics were discussed for their ability to improve functional capacity and reduce congestion. Panelists highlighted that effective care must also address comorbidities and psychosocial factors that contribute to readmissions and diminished well-being.
Ultimately, enhancing quality of life requires coordinated, patient-centered care. Regular monitoring, medication optimization, and shared decision-making empower patients to manage their symptoms more effectively and prevent recurrent hospitalizations.
